Rezolute, Inc. (RZLT) is a pharmaceutical preparations company incorporated in NV, listed on the Nasdaq. With a market capitalization of $307 million, Rezolute, Inc. is a small-cap company. The stock currently trades at $3.16, down 1.55% today, with a 52-week range of $1.07–$11.46.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.98 | $-0.98 | +26.3% | |
| 2024 | $-1.33 | $-1.33 | -31.7% | |
| 2023 | $-1.01 | $-1.01 | +56.5% | |
| 2022 | $-2.32 | $-2.26 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | $-1.04 | $-1.04 | -477.8% | |
| 2013 | $-0.18 | $-0.18 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-06-30 | 2025-09-17 | 0001104659-25-090848 | SEC ↗ |
| 2024-06-30 | 2024-09-19 | 0001558370-24-012901 | SEC ↗ |
| 2023-06-30 | 2023-09-14 | 0001558370-23-015755 | SEC ↗ |
| 2022-06-30 | 2022-09-15 | 0001558370-22-014432 | SEC ↗ |
| 2021-06-30 | 2021-09-15 | 0001104659-21-115980 | SEC ↗ |
| 2020-06-30 | 2020-10-13 | 0001104659-20-114497 | SEC ↗ |
| 2019-06-30 | 2019-09-10 | 0001144204-19-043983 | SEC ↗ |
| 2018-06-30 | 2018-10-15 | 0001144204-18-053849 | SEC ↗ |
| 2017-06-30 | 2017-09-22 | 0001144204-17-049237 | SEC ↗ |
| 2016-06-30 | 2016-09-28 | 0001144204-16-125780 | SEC ↗ |
| 2015-06-30 | 2015-09-28 | 0001144204-15-057284 | SEC ↗ |
| 2014-06-30 | 2014-09-30 | 0001144204-14-058476 | SEC ↗ |
| 2013-06-30 | 2013-09-11 | 0001144204-13-050267 | SEC ↗ |
| 2012-06-30 | 2012-11-05 | 0001144204-12-059437 | SEC ↗ |
| 2011-06-30 | 2011-09-22 | 0001144204-11-054372 | SEC ↗ |